Analytical Method Development and Validation Supporting Drug Development

Analytical Method Development and Validation Supporting Drug Development

Products & Services

Information

Our highly skilled method development scientists have acquired years of experience, working across many types of products, methods and analytical technologies to ensure that the method will be 'fit for purpose' for APIs, raw materials, excipients, drug products or packaging. Our expertise spans a variety of molecules and formulations that include small molecules, biologics, nanoparticles, solids, patches, gels, ointments, liquids and inhaled products. Intertek’s laboratories are equipped with sophisticated analytical technologies including chromatography, mass spectrometry, elemental analysis and spectroscopy. Our teams are experienced with sample preparation techniques which may include procedures for trace levels of analysis and approaches suitable to the physical and chemical properties of the matrix and the dosage form. Method Validation Contract Services By working with Intertek, you gain an experienced partner with a good working knowledge of method validation requirements suitable for different phases of development. To ensure methods meet regulatory requirements we follow relevant ICH guidelines such as ICH Q2 (R1) or Pharmacopoeial methods/compendia guidance in combination with client-specific protocols. Analytical Method Lifecycle Management Your method validation requirements and analytical methods will most likely evolve over the commercial lifecycle, from early-stage development through to commercial use. Our strengths in assessing existing method validation, identifying gaps and validation remediation or improvement planning are coupled with vast method optimization experience for many sample types, helping to ensure a successful validation. Find out more: https://www.intertek.com/pharmaceutical/analysis/method-development-validation/
Intertek213Intertek Pharmaceutical Services – Bringing Quality, Safety and Sustainability to Life. Our bespoke, purpose-built GLP / GCP / GMP laboratories have supported developers and manufacturers for over 30 years by providing bioanalytical studies and advanced characterisation programs. We have worked on multiple studies involving cell or gene therapies, mRNA, plasmid DNA based products, and other advanced modalities. Our facility has been designed to handle recombinant genomic materials for the purposes of research and compliant testing, including specialist facilities for handling Class I and Class II Biological Agents. Intertek’s innovative bio/pharmaceutical services are delivered consistently with precision, pace, and passion, enabling you, our customer, to power ahead safely. Our solutions: • Cell and virus characterisation • Virology assays • Host cell and residual plasmid DNA • Cell-based assays / potency testing • General compendial testing • GMP analysis • GCP/GLP bioanalysis • ICH stability storage and testing • Method development and validation • QC release testing • Advanced delivery technology analytical support Find out more: www.intertek.com/pharmaceutical/biopharmaceuticals/gene-therapy-characterisation Contact us today: +44 (0)116 296 1620 | pharma.services@intertek.com Follow us: www.linkedin.com/showcase/intertek-pharma  ATMP Analytical Development Services & CMC Support Presentation Request | AAV Therapies: Developing Effective Analytical Strategies for In-Depth Empty vs Full Capsid Characterization > Brochure | Cell and Gene Therapies Analytical Development Services >

Log in

See all the content and easy-to-use features by logging in or registering!